National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1965. No. 51.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1964.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1964.

Dated this 29th

day of  April,  1965.

DE L’ISLE

Governor-General.

By His Excellency’s Command,

(Sgd) R. W. Swartz.

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of May, 1965.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE

Regulation 10

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical Benefits.

Acetomenaphthone.

Acetomenaphthone Tablets.

Acetrizoic Acid.

Alcohol (95%).

Dilute Alcohols.

Dehydrated Alcohol.

Almond Oil.

Amethocaine Hydrochloride

Ammoniated Mercury.

Ammoniated Mercury Ointment.

Amodiaquine Hydrochloride.

Amphetamine Sulphate.

Amylobarbitone Sodium Tablets.

Antazoline Hydrochloride.

Antimony Potassium Tartrate.

Antimony Potassium Tartrate Injection.

Antimony Sodium Tartrate.

Antimony Sodium Tartrate Injection.

Apomorphine Hydrochloride.

Apomorphine Injection.

Bacillus Calmette-Guérin Vaccine.

Bemegride.

Benzhexol Hydrochloride.

Benztropine Methanesulphonate.

Botulinum Antitoxin.

Busulphan.

Butobarbitone.

Calciferol.

Calciferol Solution.

Caramiphen Hydrochloride.

Caraway.

Carbachol.

Carbimazole.

Carbon Dioxide.

* Notified in the Commonwealth Gazette on 30 April 1965

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; and 1964, Nos. 12, 57 and 135.

3284/65.—Price 6d. 9/30.3.1965.

First Schedule—continued.

 

Carbromal Tablets.

Cardamom Fruit.

Cascara.

Catgut, Sterilised Surgical.

Cellulose, Oxidised.

Cetylpyridinium Chloride.

Chlorambucil.

Chlorcyclizine Hydrochloride.

Chloroquine Phosphate.

Chloroquine Sulphate.

Chlorothiazide.

Chlorphenesin.

Chlorpropamide.

Chorionic Gonadotrophin.

Chorionic Gonadotrophin Injection.

Cinchocaine Hydrochloride.

Cinnamon.

Citric Acid, Anhydrous.

Cochineal

Colchicine.

Colchicum Corm.

Colchicum Liquid Extract.

Coriander.

Corticotrophin.

Cresol and Soap Solution.

Cresol.

Crotamiton.

Cyanocobalamin.

Cyclizine Tablets.

Cyclobarbitone Calcium.

Cyclomethycaine Sulphate.

Cyclopropane.

Dapsone.

Deoxycortone Trimethylacetate.

Dequalinium Acetate.

Dequalinium Chloride.

Dexamethasone.

Dexamethasone Acetate.

Dexamphetamine Sulphate.

Dextromethorphan Hydrobromide.

Dextromethorphan Tablets.

Diamorphine Hydrochloride.

Diamorphine Injection.

Dibromopropamidine Isethionate.

Dichlorphenamide.

Diethazine Hydrochloride.

Diethylcarbamazine Citrate.

Digitoxin.

Diloxanide Furoate.

Dimenhydrinate.

Dimenhydrinate Injection.

Dimenhydrinate Tablets.

Dimercaprol.

Dimethisterone.

Dimethisterone Tablets.

Diodone Injection.

Diphtheria and Pertussis Vaccine.

Dipipanone Hydrochloride.

Dipipanone Injection.

Domiphen Bromide.

Edrophonium Chloride.

Emetine and Bismuth Iodide.

Emetine Hydrochloride.

 

Erythromycin.

Ethinyloestradiol

Ethisterone.

Ethopropazine Hydrochloride.

Ethotoin.

Ethyl Chloride.

Ethyl Oleate.

Ethylenediamine Hydrate.

Eugenol.

Fludrocortisone Acetate.

Fluoxymesterone.

Gallamine Triethiodide.

Gallamine Injection.

Gelatin Sponge, Absorbable.

Gentian.

Ginger.

Glutethimide.

Griseofulvin.

Guanethidine Sulphate.

Halothane.

Helium.

Heparin.

Hexamethonium Tartrate.

Hexamethonium Tartrate Injection.

Hexylresorcinol.

Histamine Acid Phosphate.

Human Blood, Whole.

Human Red Blood Corpuscles, Concentrated.

Human Fibrin Foam.

Human Fibrinogen.

Human Gamma Globulin.

Human Gamma Globulin Injection.

Human Plasma, Dried.

Human Serum, Dried.

Human Thrombin.

Hydrallazine Hydrochloride.

Hydrallazine Tablets.

Hydrochlorothiazide.

Hydrocortisone Ointment.

Hydrocortisone Acetate Ointment.

Hydrocortisone Hydrogen Succinate.

Hydroflumethiazide.

Hydrogen Peroxide Solution, Strong.

Hydroxocobalamin.

Hydroxychloroquine Sulphate.

Hyoscyamus.

Imipramine Hydrochloride.

Indigo Carmine.

Influenza Vaccine.

Iodipamide Methylglucamine Injection.

Iodised Oil Fluid Injection.

Iodised Oil Viscous Injection.

Iopanoic Acid.

Iopanoic Acid Tablets.

Iophendylate Injection.

Ipecacuanha, Prepared.

Ipecacuanha and Opium Tablets.

Isoniazid.

Isopropyl Alcohol.

Lead Acetate.

Lead Monoxide.

Lemon Peel, Dried.

Lignocaine Hydrochloride.

Lignocaine and Adrenaline Injection.

First Schedule—continued

Lignocaine Hydrochloride Injection.

Liothyronine Sodium.

Lucanthone Hydrochloride.

Lucanthone Tablets.

Magnesium Stearate.

Male Fern.

Maleic Acid.

Mannitol.

Mecamylamine Hydrochloride.

Melarsoprol.

Menaphthone Sodium Bisulphite.

Mepacrine Hydrochloride.

Mephentermine Sulphate.

Meprobamate.

Meprobamate Tablets.

Mercaptopurine.

Mersalyl Acid.

Methadone Hydrochloride.

Methandienone.

Methoin.

Methyl Hydroxybenzoate.

Methylamphetamine Hydrochloride.

Methylthiouracil.

Methylthiouracil Tablets.

Methyprylone.

Methyprylone Tablets.

Mustine Hydrochloride.

Nalorphine Hydrobromide.

Nandrolone Phenylpropionate.

Naphazoline Hydrochloride.

Neostigmine Bromide.

Nicotinic Acid.

Nikethamide.

Nikethamide Injection.

Nitrous Oxide.

Norethisterone.

Norethisterone Tablets.

Noscapine.

Nux Vomica.

Oestradiol Benzoate.

Opium.

Opium, Powdered.

Orange Peel, Dried Bitter.

Orange Peel, Fresh Bitter.

Oxygen.

Oxytetracycline Dihydrate.

Paramethadione.

Pempidine Tartrate.

Pentamidine Isethionate.

Pentamidine Injection.

Perphenazine.

Perphenazine Tablets.

Pethidine Tablets.

Phanquone.

Phanquone Tablets.

Phenelzine Sulphate.

Phenelzine Tablets.

Phenindamine Tartrate.

Phenindione.

Phenolphthalein Tablets.

Phenolsulphonphthalein.

Phenoxybenzamine Hydrochloride.

Phenoxymethylpenicillin.

Phentolamine Hydrochloride.

Phentolamine Tablets.

Phentolamine Methanesulphonate.

Phentolamine Injection.

Phytomenadione.

Phytomenadione Capsules.

Phytomenadione Tablets.

Picrotoxin.

Piperazine Citrate.

Piperazine Phosphate.

Piperocaine Hydrochloride.

Poliomyelitis Vaccine (Inactivated).

Poliomyelitis Vaccine (Oral).

Potassium Chloride Injection.

Potassium Perchlorate.

Prednisone Acetate.

Primaquine Phosphate.

Primidone.

Probenecid.

Procaine and Adrenaline Injection.

Prochlorperazine Maleate.

Prochlorperazine Methanesulphonate.

Prochlorperazine Tablets.

Procyclidine Hydrochloride.

Progesterone.

Proguanil Hydrochloride.

Promazine Hydrochloride.

Promazine Injection.

Promazine Tablets.

Promethazine Theoclate.

Promethazine Theoclate Tablets.

Propyl Gallate.

Propyl Hydroxybenzoate.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propylthiouracil.

Pyridostigmine Bromide.

Pyrimethamine.

Quillaia.

Rabies Antiserum.

Rabies Vaccine.

Schick Control.

Senna Leaf.

Sesame Oil.

Soda Lime.

Sodium Acetrizoate Injection.

Sodium Anoxynaphthonate.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Bicarbonate Injection.

Sodium Calciumedetate.

Sodium Chromate (51 Cr) Injection.

Sodium Diatrizoate.

Sodium Diatrizoate Injection.

Sodium Fluoride.

Sodium Iodide (131 I) Injection.

Sodium Iodide (131 I) Solution.

Sodium Lauryl Sulphate.

Sodium Phosphate (32 P) Injection.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsone Tablets.

Staphylococcus Antitoxin.

Stibophen.

Stibophen Injection.

Stramonium.

First Schedule—continued

Sulphadimidine Sodium.

Sulphamethizole.

Sulphamethoxypyridazine.

Sulphasomidine.

Sulphasomidine Tablets.

Sulphobromophthalein Sodium.

Suramin.

Suramin Injection.

Suxamethonium Bromide.

Suxamethonium Chloride

Testosterone.

Testosterone Phenylpropionate.

Testosterone Phenylpropionate Injection.

Testosterone Propionate.

Tetrachloroethylene.

Tetrachloroethylene Capsules.

Thiambutosine.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thioridazine Hydrochloride.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Trichloroethylene.

Trifluoperazine Hydrochloride.

Tripelennamine Hydrochloride.

Tryparsamide.

Tryparsamide Injection.

Tuberculin, Old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B and Tetanus Vaccine.

Typhoid-Paratyphoid A, B, and C Vaccine.

Undecenoic Acid.

Vinyl Ether.

Vitamin A Ester Concentrate.

Yellow Fever Vaccine.

Zinc Undecenoate.

Zinc Undecenoate Ointment.

SECOND SCHEDULE

Regulation 10 (3)

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

Pharmaceutical Benefits	Allowable Compounds (if any)
Acrylic Resin......................................	—
Adrenaline Acid Tartrate, B.P..............	—
Aluminium Powder, B.P.C ..................	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
Aluminium Hydroxide Gel Dried, B.P.	Aluminium Hydroxide Gel Dried B.P. with Magnesium Hydroxide B.P.C.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Carbonate B.P.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.C.
Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Aluminium Hydroxide Gel Dried B.P.
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Aluminium Sodium Silicate.................	Aluminium Sodium Silicate with Belladonna
Amphotericin B..................................	Tetracycline with a buffering agent and Amphotericin B.
Aneurine Hydrochloride, B.P...............	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Antazoline Sulphate............................	Antazoline Sulphate with Naphazoline Nitrate B.P.

 

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Ascorbic Acid, B.P........................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite.....................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin, B.P...............................	Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Betamethasone Disodium Phosphate	—
Betamethasone Phosphate..............	—
Calcium Lactobionate....................	Thenalidine with Calcium Lactobionate
Carbinoxamine Maleate..................	—
Carbromal, B.P..............................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C.........................	—
Chloramphenicol, B.P....................	Chloramphenicol B.P. with Polymyxin B, Sulphate B.P.
Chlorhexidine Gluconate ...............	—
Chlorpheniramine Maleate, B.P......	—
Chlorpromazine Hydrochloride, B.P.	—
Chlortetracycline Hydrochloride, B.P.	—
Clemizole Tannate.........................	—
Cortisone Acetate, B.P...................	—
Cymogran.....................................	—
Cyproheptadine Hydrochloride.......	—
Cyclizine Hydrochloride, B.P.........	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide....................	—
Demethylchlortetracycline Hydrochloride, B.P.	—
Dexchlorpheniramine Maleate........	—
Dextran.........................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.C.	—
Dienoestrol, B.P.............................	—
Digoxin, B.P..................................	—
Dihydrostreptomycin Sulphate, B.P. 1958	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
Dihydrotachysterol.........................	—
Dimethicone..................................	—
Diphenhydramine Hydrochloride, B.P.	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphenylpyraline Hydrochloride.....	—
Diphtheria Vaccine, B.P.................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Dyflos, B.P.C................................	—
Ecothiopate Iodide.........................	—
Entsufon........................................	Hexachlorophane B.P. with Entsufon
Ergometrine Maleate .....................	Oxytocin with Ergometrine Maleate
Ergotamine Tartrate, B.P................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions......	—
Ethosuximide ................................	—

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Ferric Hydroxide.................................	—
Ferrous Aminoacetosulphate................	—
Ferrous Gluconate, B.P........................	—
Ferrous Succinate ...............................	—
Framycetin Sulphate ...........................	—
Galactomin ........................................	—
Glucose Indicator................................	—
Gramicidin.........................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Hamamelis Dry Extract, B.P.C............	Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P.
Hexachlorophane, B.P.........................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Lissapol
Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P............................	—
Hydrocortisone Acetate, B.P................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Ipecacuanha, B.P................................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride .................	—
Kanamycin Sulphate, B.P.C. ...............	—
Levallorphan Tartrate, B.P...................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol .............................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol
Lofenalac ..........................................	—
Magnesium Bicarbonate Solution, B.P. 1948	—
Magnesium Chloride...........................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C.	—
Meclozine Hydrochloride, B.P.............	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P...................	—
Methdilazine Hydrochloride ...............	—
Methyl Glucamine ..............................	Theophylline B.P. with Methyl Glucamine
Minafen .............................................	—
Morphine Tartrate ..............................	Morphine Tartrate with Tacrine
Naphazoline Nitrate, B.P.....................	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P......................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Neostigmine Methylsulphate, B.P.	—
Nicotinamide, B.P...............................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Nitrofurantoin, B.P..............................	—
Nystatin, B.P......................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride, B.P.	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytocin............................................	Oxytocin with Ergometrine Maleate
Pancreatin Enzyme, U.S.N.F. XI .........	—
Papaveretum, B.P.C............................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Paracetamol, B.P.................................	—

 

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Penicillin, Benethamine, B.P.C............	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P..................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P........................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)	—
Penicillin, Potassium, B.P....................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P......................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P.......................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P....................	Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P.
Pertussis Vaccine, B.P. .......................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P.	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Phenethicillin Potassium .....................	—
Pheniramine Maleate ..........................	—
Phenytoin...........................................	—
Pipenzolate Methobromide..................	—
Pituitary (Posterior Lobe), Powdered, B.P.C.	—
Polymyxin B. Sulphate, B.P.................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic Acid
Prednisolone, B.P................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Methylprednisolone, B.P.....................	—
Prednisolone Sodium Hemisulphate	—
Prednisolone Sodium Phosphate, B.P.C.	—
Prednisolone Trimethylacetate, B.P.	—
Prednisone, B.P..................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Promethazine Hydrochloride, B.P.	—
Riboflavine, B.P.................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Senna Fruit, B.P..................................	—

 

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Silver Nitrate, Toughened, B.P.............
Sobee.................................................	—
Sodium Lactate...................................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate, B.P.C.	Compound Effervescent Powder, B.P.C.

Sodium Tauroglycocholate, B.P.C. 1954	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C...........................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Strychnine, B.P.C. 1959 .....................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
Sulphacetamide, B.P.C........................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphadimethoxine, B.P.C...................	—
Sulphafurazole, B.P.............................	—
Sulphamerazine, B.P. 1958 .................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphamethoxydiazine........................	—
Sulphamethoxypyridazine N-Acetyl	—
Sulphaphenazole, B.P.C......................	—
Sulphathiazole, B.P.C..........................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement.................................	—
Tacrine...............................................	Morphine Sulphate B.P. with Tacrine
Morphine Tartrate with Tacrine
Tetanus Vaccine, B.P..........................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride, B.P..........	Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline........................................	Tetracycline with a buffering agent and Amphotericin B.
Tetracycline with a buffering agent and Nystatin B.P.
Thenalidine........................................	Thenalidine with Calcium Lactobionate
Thenalidine Tartrate ...........................	Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobromine, B.P.C............................	Theobromine B.P.C. with Phenobarbitone B.P.
Thioridazine ......................................	—
Tragacanth (Gum Karaya) ..................	—
Trimeprazine Tartrate, B.P.C...............	—
Triprolidine Hydrochloride, B.P.C.	—
Vasopressin .......................................	—
Velactin..............................................	—
Viomycin Pantothenate.......................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P......................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Embonate .........................	—
Vitamin A ..........................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D ..........................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE

Regulation 11

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

Acetazolamide Sodium.

Acetohexamide.

Acidified Golden Syrup, A.P.F. 1955.

Acriflavine, B.P.C.

Acrylic Resin.

Adrenaline Hydrochloride.

Adrenaline Mucate.

Agar B.P.C. 1954.

Alkavervir.

Aloin B.P.C.

Almond Oil Volatile Bitter, B.P.C. 1959.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Hydroxide Mixture, A.P.F.

Aluminium Hydroxide Mixture, A.P.F. 1955.

Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.

Aluminium. Sodium Silicate.

Aluminium Powder, B.P.C.

Amaranth Solution, A.P.F.

Amaranth Solution, Compound, A.P.F.

Amaranth Solution, B.P.C.

Amidopyrine, B.P.C. 1954.

Amitriptyline Hydrochloride.

Ammonia Aromatic Spirit, B.P.C.

Ammonia Solution Strong, B.P.C.

Ammonium Bicarbonate, B.P.C.

Ammonium Bromide, B.P.C.

Amphotericin B.

Ampicillin.

Antazoline Methanesulphonate, B.P.C.

Antazoline Sulphate.

Attapulgite.

Aurothioglucose.

Beclamide.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Benedict’s Solution, A.P.F.

Benzalkonium Chloride.

Benzoinated Lard, B.P.C. 1954.

Benzoin Compound Tincture, B.P.C.

Benzoin Tincture, B.P.C.

Benzylpenicillin in Oil.

Bephenium Hydroxynaphthoate, B.P.C.

Betamethasone.

Betamethasone Disodium Phosphate.

Betamethasone Phosphate.

Bethanidine Sulphate.

Bismuth Subgallate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Cade Oil, B.P.C.

Caffeine and Sodium Benzoate, B.P.C. 1954.

 

Caffeine Citrate, B.P.C. 1959.

Cajuput Spirit, B.P. 1948.

Calamine Cream, A.P.F. 1955.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Gluconogalactogluconate.

Calcium Lactobionate.

Calcium Phosphate, B.P.C.

Calumba, Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Carbamazepine.

Carbarsone, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Chloramine, B.P.C.

Chloramphenicol Palmitate, B.P.C.

Chloramphenicol Stearate.

Chloramphenicol Succinate.

Chlorazanil Hydrochloride.

Chlorhexidine Diacetate.

Chlorhexidine Gluconate.

Chlorobenzol Disulphonamide.

Chlorotrianisene, B.P.C.

Chlorthalidone, B.P.C.

Choline Theophyllinate, B.P.C.

Cinnamon Spirit, B.P.C. 1949.

Cinnamon Water, Concentrated, B.P.C.

Clemizole Hydrochloride.

Clemizole Tannate.

Clopamide.

Clove, Concentrated Infusion, B.P.C. 1954.

Cloxacillin Sodium.

Coal Tar, B.P.C.

Cochineal Tincture, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Colistin.

Copper Sulphate, B.P.C.

Creosote, B.P.C. 1959.

Cudbear Tincture, A.P.F. 1947.

Curd Soap, B.P.C.

Cyclopenthiazide.

Cyclophosphamide.

Cyclothiazide.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine Hydrochloride.

Death Adder Antivenene.

Demecarium Bromide.

Deoxycortone Glucoside.

Desferrioxamine.

Deslanoside.

Dexamethasone Sodium Phosphate.

Third Schedule—continued

Dexchlorpheniramine Maleate.

Dextran.

Dextriferron.

Dicyclomine Hydrochloride, B.P.C.

Digitalis Tincture, B.P.C. 1959.

Dihydroergotamine Methanesulphonate.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

Dihydrostreptomycin Sulphate, B.P. 1958.

Dihydrotachysterol.

Dimethicone, B.P.C.

Diphenylpyraline Hydrochloride.

Dipyridamole.

Disodium Stilboestrol Diphosphate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate Iodide.

Entsufon.

Ephedrine, B.P.C.

Ergot, Liquid Extract, B.P. 1914.

Erythromycin Ethyl Succinate.

Erythromycin Glucoheptonate.

Erythromycin Lactobionate.

Erythromycin Stearate.

Ethanolamine, B.P.C.

Ethanolamine Oleate.

Ether Nitrous Spirit, B.P.C. 1959.

Ethionamide.

Ethosuximide.

Ethoxzolamide.

Ethyl Biscoumacetate, B.P.C.

Ethylidene Dicoumarin.

Ethylnoradrenaline Hydrochloride.

Ethyloestrenol.

Eucalyptol, B.P.C.

Extract of Ox Bile, B.P. 1948.

Ferric Hydroxide.

Ferrous Aminoacetosulphate.

Ferrous Carbonate Saccharated, B.P.C. 1959.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Folinic Acid.

Framycetin Sulphate.

Frusemide.

Fusidic Acid, Diethanolamine Salt.

Fusidic Acid, Sodium Salt.

Galactomin.

Gall and Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Glucagon Hydrochloride.

Glucose Indicator.

Glycerophosphate Compound Syrup, A.P.F. 1955.

Goats Milk, dehydrated.

Gramicidin.

Haemophilus Influenzae Bacterial Serum.

Hamamelis Dry Extract, B.P.C.

Hamamelis Liquid Extract, B.P.C.

Heparin Retard.

  

Hexocyclium Methylsulphate.

Honey, Purified, B.P.C.

Hydrargaphen.

Hydrocyanic Acid, Dilute, B.P.C. 1954.

Hydroxyprogesterone Caproate.

Hyoscine Methobromide.

Hypophosphorous Acid, Dilute, B.P.C.

Idoxuridine.

Indomethacin.

Insulin Injection, specially purified.

Insulin Isophane Injection, specially purified.

Insulin Injection, Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform, B.P.C. 1954.

Iron Aminoates.

Iron Dextran.

Iron Oxide Saccharated.

Iron Sorbitol Complex.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride, B.P.C.

Kanamycin Sulphate, B.P.C.

Kitasamycin.

Lanatoside-C.

Lavender Spike Oil, B.P.C.

Lemon Tincture, B.P. 1958.

Lissapol.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Lypressin.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Magnesium Chloride.

Magnesium Hydroxide, B.P.C.

Mebhydrolin Napadisylate, B.P.C.

Medroxyprogesterone Acetate.

Mercaptomerin Sodium.

Mestanolone.

Metaraminol Bitartrate.

Metformin Hydrochloride.

Methacycline.

Methazolamide.

Methdilazine Hydrochloride.

Methenamine Mandelate.

Methenolone Acetate.

Methenolone Oenanthate.

Methotrexate.

Methoxamine Hydrochloride, B.P.C.

Methsuximide.

Methyclothiazide.

Methyldopa.

Methyl Glucamine.

Methylphenobarbitone, B.P.C.

Methylprednisolone Acetate.

Metronidazole, B.P.C.

Minafen.

Mitomycin.

Morphine Tartrate.

Myrrh Gum, Powdered, B.P.C.

Myrrh Tincture, B.P.C.

Nalidixic Acid.

Nandrolone Decanoate.

Niclosamide.

Third Schedule— continued

Nicotinyl Alcohol Tartrate.

Nicoumalone.

Nitromin.

Nux Vomica, Dry Extract, B.P.C.

Oestradiol Dipropionate, B.P.C. 1954.

Oestrone, B.P.C. 1954.

Oily Ophthalmic Vehicle, A.P.F. 1955.

Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.

Orange Peel, Concentrated Infusion, B.P.C.

Orciprenaline Sulphate.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxymesterone.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Oxytocin.

Pancreatin Enzyme, U.S.N.F. XI.

Papaveretum, B.P.C.

Para-Aminosalicylic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955

Paraben Ophthalmic Vehicle, A.P.F. 1955.

Paraffin Liquid Light, B.P.C.

Paramethasone Acetate.

Pargyline Hydrochloride.

Pectin.

d-Penicillamine Hydrochloride, B.P.C.

Penicillinase.

Penicillin, Benethamine, B.P.C.

Pentaerythritol Tetranitrate, diluted, B.P.C.

Penthienate Methobromide.

Pertussis Vaccine (Haemagglutinin Aluminium Phosphate Adsorbed).

Peru Balsam, B.P.C.

Phenazone, B.P.C.

Phenazopyridine Hydrochloride.

Phenethicillin Potassium.

Phenformin Hydrochloride.

Pheniramine Maleate.

Pheniramine Para-Aminosalicylate.

Phenol Ointment, B.P. 1948.

Phenoxymethylpenicillin, Benzathine.

Phenoxymethylpenicillin, Hydrabamine.

Phensuximide.

Phenytoin.

Phthalylsulphacetamide.

Physostigmine, B.P.C.

Pipenzolate Methobromide.

Pituitary (Posterior Lobe) Powdered, B.P.C.

Polythiazide;

Potable Water.

Potassium Chlorate, B.P.C.

Potassium, Effervescent Tablets.

Prednisolone Sodium Hemisuccinate.

Prednisolone Sodium Hemisulphate.

Prednisolone Sodium Phosphate, B.P.C.

Prednisolone Tertiary Butyl Acetate.

Protoveratrine A.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Quillaia Tincture, B.P.C.

Quinethazone.

  

Rauwolfia Alkaloids.

Red Back Spider Antivenene.

Rolitetracycline.

Salicylamide.

Senega, Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C. 1959.

Senna, Concentrated Infusion, B.P.C. 1959.

Senna Fruit Extract (Standardised).

Siberian Fir Oil, B.P.C. 1949.

Silver Protein, B.P.C.

Silver Protein Mild, B.P.C.

Sobee.

Sodium Carbonate Anhydrous, B.P.C.

Sodium Edetate, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Potassium Tartrate, B.P.C.

Sodium Tauroglycocholate, B.P.C. 1954.

Sorbolene, A.P.F. 1955.

Spearmint Oil, B.P.C.

Spiramycin.

Spironolactone, B.P.C.

Squill Tincture, B.P.C.

Stanolone.

Stearic Acid, B.P.C.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C. 1959.

Sulphacetamide, B.P.C.

Sulphadiazine Sodium, B.P.C.

Sulphadimethoxine, B.P.C.

Sulphaguanidine, B.P.C.

Sulphamerazine, B.P. 1958.

Sulphamethoxydiazine.

Sulphamethoxypyridazine N-Acetyl.

Sulphaphenazole, B.P.C.

Sulphapyridine, B.P.C. 1959.

Sulphasalazine.

Sulphathiazole, B.P.C.

Sulphinpyrazone, B.P.C.

Sulphurated Potash, B.P.C.

Sulphuric Acid, Dilute, B.P.C.

Sulphur Sublimed, B.P.C.

Sultiame.

Surgical Cement.

Sustanon.

Syrup Glucose Liquid, B.P.C.

Tacrine.

Taipan Antivenene.

Tar Ointment, B.P.C. 1959.

Tartrazine, B.P.C. 1954.

Testosterone Oenanthate.

Tetracycline.

Thenalidine.

Thenalidine Tartrate.

Theobromine, B.P.C.

Theobromine and Sodium Salicylate, B.P. 1953.

Theophylline Elixir.

Theophylline Ethanoate of Piperazine.

Thiethylperazine.

Thioridazine.

Thiotepa.

Thyrotrophin.

Tiger Snake Antivenene.

Third Schedule—continued

Tolu Tincture, B.P.C. 1959.

Tragacanth (Gum Karaya).

Tretamine.

Triamcinolone, B.P.C.

Triamterene.

Triaziquone.

Tricyclamol Chloride.

Tridihexethyl Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Trimeprazine Tartrate, B.P.C.

Trimustine Hydrochloride.

Trinitrophenol, B.P.C. 1959.

Triprolidine Hydrochloride, B.P.C.

Vadrine.

Valerian Ammoniated Tincture, B.P.C.

Vanillin.

Vasopressin Tannate.

Velactin.

Vinblastine Sulphate.

Vincristine Sulphate.

Vinegar of Squill, B.P.C.

Viomycin Pantothenate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

–––––––––––––––––––

FOURTH SCHEDULE

Regulation 12

Additives

Acetone, B.P.C.

Alcohol (95%), B.P.

Dilute Alcohols, B.P.

Amethocaine Hydrochloride, B.P.

Caraway Oil, B.P.C.

Carmine Solution, A.P.F.

Citronella Oil, B.P.C.

Xylene, B.P.C. 1949.

FIFTH SCHEDULE

Regulation 14

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Acetylsalicylic Acid Tablets, B.P...........
Soluble Acetylsalicylic Acid Tablets, B.P.	Any disease or condition in a pensioner
Compound Acetylsalicylic Acid Tablets, A.P.F.
Compound Acetylsalicylic Acid Tablets, B.P.C.
Soluble Compound Acetylsalicylic Acid Tablets
Acrylic Resin........................................	Ileostomy or colostomy conditions
Alkavervir............................................	Hypertensive crises

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Amitriptyline Hydrochloride..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride
Amphotericin B....................................	Systemic fungal infection
Ampicillin Capsules .............................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic
Ampicillin Injections.............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ampicillin Tablets................................
Aneurine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner
Ascorbic Acid Tablets, B.P....................
Beclamide ...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Bemegride Injection, B.P.......................	As an antidote to barbiturate and other hypnotic poisons
Bendrofluazide Injection .......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Betamethasone Tablets .........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Betamethasone Disodium Phosphate Injection	Intra-articular use
Bethanidine Sulphate ............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Busulphan Tablets, B.P.........................	Leukaemia
Calciferol Tablets, B.P..........................	Any disease or condition in a pensioner
With the written authority of the Director-General—
Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calcium Aminosalicylate ......................	Tuberculosis
Calcium Gluconogalactogluconate Effervescent Tablets	Hypoparathyroidism
Caramiphen Tablets, B.P.......................	Parkinsonism
Carbamazepine ....................................	Epilepsy
Trigeminal neuralgia
Chlorambucil Tablets, B.P.....................	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P.............	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Chloramphenicol Injections ..................	disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets ......................
Chloramphenicol Oral Suspension
Chlorotrianisene Tablets .......................	Carcinoma of the prostate
Chlorpromazine Hydrochloride .............	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride
Chlortetracycline Capsules, B.P.............	Brucellosis
Herpes zoster ophthalmicus
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins.
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Chlortetracycline Hydrochloride Granules	A disease or condition, specified in this column in relation to Chlortetracycline Capsules
Choline Theophyllinate.........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cloxacillin Sodium ...............................
Compound Codeine Tablets, B.P............
Compound Codeine Soluble Tablets, B.P.	Any disease or condition in a pensioner
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid Tablets
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets
Cod Liver Oil Emulsion ........................	Any disease or condition in a child under the age of twelve years or in a pensioner
Colistin ................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

With the written authority of the Director-General—
Corticotrophin Injection, B.P...............................................	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection, B.P.
	Hypsarrhythmia
Corticotrophin Zinc Hydroxide Injection, B.P.	Salaam convulsions
	The prevention of side effects of corticosteroid therapy
Cortisone Injection, B.P..............................................		With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatomyositis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
Leucine-sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act
Cortisone Injection, B.P.—continued	Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Type II Nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
Cortisone Tablets, B.P...........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection, B.P. (other than 1,000 microgram strength)	Established megalocytic anaemia
Cyanocobalamin Injection, B.P. (1,000 microgram strength)	Neuroblastoma
Subacute combined degeneration of the cord
Cymogran ............................................	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine Capsules, B.P.....................
Demethylchlortetracycline Capsules, B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections	Addison’s disease
Deoxycortone Acetate Injection, B.P.
Deoxycortone Trimethylacetate Injection, B.P.
	Adrenalectomy, total
Deoxycortone Acetate Implants, B.P.
Deoxycortone Acetate Tablets ..............
Desferrioxamine ..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P..................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dextran with Dextrose ..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dextran in Normal Saline .....................
Dienoestrol Cream ...............................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P........................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol................................	Parathyroid deficiency
Diiodohydroxyquinoline Vaginal Tablet	Trichomonal or monilial vaginitis
Diiodohydroxyquinoline Effervescent Gynaecological Pessary

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Diloxanide Furoate Tablets, B.P.............	Amoebic dysentery
Dimethicone ........................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate	Carcinoma of the prostate
Dithiazanine Iodide...............................	Infestations of Trichuris trichiura or Strongyloides stercoralis
Ditophal...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin .......................................	Staphylococcal septicaemia or pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
Ethinyloestradiol Tablets, B.P................	Turner’s syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethionamide.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethisterone Tablets, B.P........................	Turner’s syndrome
Ethyloestrenol.......................................	Mammary carcinoma
Senile osteoporosis proven by radiological report
With the written authority of the Director-General, long-term corticosteroid therapy
Fludrocortisone Tablets, B.P..................	Addison’s disease
Adrenocortical hypoplasia
Fluoxymesterone Tablets, B.P................	Castration syndrome (male and female)
Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy
Folic Acid Injection..............................	Macrocytic anaemia
Folic Acid Tablets, B.P.........................	Sprue or the sprue-like syndrome
Folinic Acid .........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets .................
Frusemide ............................................
Fusidic Acid (Sodium Salt or Diethanolamine Salt)
Galactomin ..........................................	With the written authority of the Director-General, galactosaemia
Goats Milk, dehydrated ........................	With the written authority of the Director-General, cows milk allergy in children under the age of four years
Griscofulvin Tablets, B.P......................	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules ...................	Any disease or condition in a pensioner
Haemophilus Influenzae Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophane with Entsufon ............
Hexachlorophane with Lissapol ............
Hexachlorophane in Soap Solution
Hydrocortisone Injection ......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P.	Intra-articular use
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
Stevens-Johnson syndrome

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Hydrocortisone Sodium Succinate Soluble Tablet	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydroxocobalamin Injection, B.P. (100 microgram strength)	Established megalocytic anaemia
Hydroxocobalamin Injection, B.P. (1,000 microgram strength)	Neuroblastoma
	Sub-acute combined degeneration of the cord
Hydroxyprogesterone Caproate ......................................................	Habitual abortion
Imipramine Tablets, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride
Indomethacin ......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Isoniazid Tablets, B.P.......................................................	Tuberculosis
Kanamycin Sulphate ......................................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Kitasamycin ......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate ......................................................	Obstetrical use
Severe intractable pain
Liothyronine Tablets, B.P.......................................................	Myxoedema
Myxoedema coma
Lofenalac ......................................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate ......................................................	Endometrial carcinoma
Mercaptopurine Tablets, B.P.......................................................	Allergic angiitis
Leukaemia
Lupus erythematosus
Periarteritis
Mestanolone ......................................................	Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy
Methacycline ......................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Methandienone Tablets, B.P.......................................................	Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy
Methenolone Acetate .......................................................
Methenolone Oenanthate ......................................................		Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Sodium ......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P.......................................................
Methotrexate Tablets .......................................................	Leukaemia and neo-plastic disease

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Methotrexate Injections ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen ....................................................	With the written authority of the Director-General, phenylketonuria
Mitomycin ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
Mustine Injection, B.P.....................................................	Malignant lymphoma and related conditions
Nalidixic Acid ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nandrolone Phenylpropionate Injection, B.P.	Mammary carcinoma
	Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy
Nandrolone Decanoate ....................................................
Neomycin Sulphate Tablets ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nicotinic Acid Tablets, B.P.....................................................	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.....................................................	Urinary tract infections
Nitrofurantoin Oral Suspension ....................................................
Nitromin .....................................................	Malignant lymphoma and related conditions
Norethandrolone ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Norethandrolone Tablets, B.P. ....................................................
Novobiocin Calcium ....................................................
Novobiocin Sodium ....................................................
Novobiocin Tablets, B.P.....................................................
Nystatin ....................................................	Proven monilia infections
Orciprenaline Sulphate ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxymesterone ....................................................	Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy
Oxytetracycline Hydrochloride Capsules	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Oxytetracycline Tablets, B.P.....................................................
Oxytetracycline Hydrochloride Injections
Calcium di-Oxytetracycline Oral Suspension
Calcium di-Oxytetracycline Paediatric Drops
Oxytocin Nasal Spray ....................................................	Induction of labour
Pancreatin, B.P.	Fibrocystic disease
Pancreatin Enzyme U.S.N.F. XI ....................................................	Pancreatico-duodenectomy
	Pancreatic steatorrhoea
Para-Aminosalicylic Acid ....................................................	Tuberculosis
Paramethasone Acetate ....................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion ....................................................
Paraffin Liquid Emulsion with Phenolphthalein ....................................................	Any disease or condition in a pensioner
Pargyline Hydrochloride ....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Penicillamine ....................................................	With the written authority of the Director-General, Wilson’s disease (hepatolenticular degeneration)
Peritoneal Dialysis Solution	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Phytomenadione Injection, B.P..............	Antidote to anticoagulants
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Polymyxin B. Sulphate Injection ...........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisolone Sodium Phosphate Retention Enema	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets, B.P......................	With the written authority of the Director-General—
Nodular non-suppurative panniculitis (Christian-Weber disease)
A disease or condition specified in this column in relation to Cortisone Injection except Total adrenalectomy, Addison’s disease or adrenocortical hypoplasia
Prednisolone Acetate Injection ..............
Prednisolone Methyl Acetate Injections	Intra-articular use
Prednisolone Tertiary Butyl Acetate Injection
Prednisolone Trimethylacetate Injections
Methylprednisolone Tablets, B.P...........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Methylprednisolone Capsules ...............
Prednisolone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel
Prednisolone Sodium Hemisuccinate	With the written authority of the Director-General, medical or surgical crises
Prednisone Tablets, B.P.........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel
Progesterone ........................................

Habitual abortion
Protoveratrine A ...................................	Hypertensive crises
Pyrazinamide .......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection, B.P................	Myasthenia gravis
Pyridostigmine Tablets, B.P...................
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy Radiation sickness
Riboflavine Tablets ..............................	Any disease or condition in a pensioner
Senna Fruit Extract (Standardized)
Sobee ..................................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Sodium Aminosalicylate .......................	Tuberculosis
Sodium Folate ......................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin ..........................................	A disease or condition specified in this column in relation to Erythromycin
Spironolactone .....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Stanolone ............................................	Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy
Stilboestrol Injection ............................	Carcinoma of the prostate
Stilboestrol Tablets, B.P........................	Mammary Carcinoma
	Any disease or condition in a pensioner
Streptomycin Sulphate Injections ..........	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine .....................................	Ulcerative colitis
Sultiame ..............................................	For use where other anticonvulsants have failed
Surgical Cement ...................................	Ileostomy or colostomy conditions
Sustanon ..............................................
Testosterone Implants, B.P....................
Testosterone Oenanthate .......................
Testosterone Propionate Injection, B.P...	Castration syndrome (male and female)
	Klinefelter Reifenstein Albright syndrome
Methyltestosterone Tablets, B.P.............	Mammary carcinoma
Methyltestosterone, B.P.........................
Tetracycline Capsules, B.P....................
Tetracycline Tablets, B.P.......................
Tetracycline Injections .........................
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Rolitetracycline ....................................
Tetracycline Granules ...........................
Tetracycline Paediatric Drops ...............
Tetracycline Oral Suspension ................
Tetracycline with a buffering agent
—Paediatric Drops
Tetracycline with a buffering agent
—Oral Suspension
Tetracycline with a buffering agent and Amphotericin B	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Tetracycline with a buffering agent and Nystatin
Theophylline Elixir ..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Thioridazine Tablets, B.P.......	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Thioridazine .........................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride
Thyrotrophin ........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth (Gum Karaya)......	Ileostomy or colostomy conditions
Tretamine.............................	Malignant lymphoma and related conditions
Triamcinolone.......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Triamterene..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triaziquone...........................
Trifluoperazine Tablets, B.P...	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride
Trimetaphan Injection, B.P.....	Hypotensive for anaesthesia
Vadrine ................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vancomycin Hydrochloride ...
Vasopressin Nasal Spray .......	Diabetes insipidus
Velactin ...............................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Vinblastine Sulphate.............................	Hodgkin’s disease
Vincristine Sulphate..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate...............................
Viomycin Sulphate Injection, B.P.
Viomycin Sulphate with Viomycin Pantothenate Combination
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.